Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption

Introduction and Objectives: To Compare serum levels of IL-12 and CXCL-10 in different etiologies of liver disease. Materials and methods: A cross-sectional and multicenter study was carried out, including subjects with alcoholism according to criteria WHO, without (OH) and with liver injury (cirrho...

Full description

Bibliographic Details
Main Authors: Hernández Santillan, M., Martínez Castillo, M., Medina Avila, Z., Lemus Peña, M, Montes de Oca Ángeles, D, Hernández Barragán, A., Pérez Hernández, J. L., Higuera de la Tijera, María de Fátima, Santana Vargas, D., Cordero Pérez, Paula, Muñoz Espinoza, Linda, Córdova Gallardo, J., Kershenobich Stalnikowitz, David, Gutiérrez Reyes, Gabriela
Format: Article
Language:English
Published: Ediciones Medicina y Cultura 2022
Subjects:
Online Access:http://eprints.uanl.mx/25582/1/25582.pdf
_version_ 1824420249924009984
author Hernández Santillan, M.
Martínez Castillo, M.
Medina Avila, Z.
Lemus Peña, M
Montes de Oca Ángeles, D
Hernández Barragán, A.
Pérez Hernández, J. L.
Higuera de la Tijera, María de Fátima
Santana Vargas, D.
Cordero Pérez, Paula
Muñoz Espinoza, Linda
Córdova Gallardo, J.
Kershenobich Stalnikowitz, David
Gutiérrez Reyes, Gabriela
author_facet Hernández Santillan, M.
Martínez Castillo, M.
Medina Avila, Z.
Lemus Peña, M
Montes de Oca Ángeles, D
Hernández Barragán, A.
Pérez Hernández, J. L.
Higuera de la Tijera, María de Fátima
Santana Vargas, D.
Cordero Pérez, Paula
Muñoz Espinoza, Linda
Córdova Gallardo, J.
Kershenobich Stalnikowitz, David
Gutiérrez Reyes, Gabriela
author_sort Hernández Santillan, M.
collection Repositorio Institucional
description Introduction and Objectives: To Compare serum levels of IL-12 and CXCL-10 in different etiologies of liver disease. Materials and methods: A cross-sectional and multicenter study was carried out, including subjects with alcoholism according to criteria WHO, without (OH) and with liver injury (cirrhosis, CiOH) and (Alcoholic Hepatitis, HA); non-alcoholic fatty liver (NAFLD) and chronic Hepatitis C (CHC), diagnosed by clinical, biochemical data. They were compared with subjects control (CT). For determination of IL-12 and CXCL-10 with Multiplex®-MERCK©. Statistical analysis by SPSS V.22 using U de Mann Whitney, p<0.05; values expressed as mean ± standard error. Results: Included 20 subjects with NAFLD, 78 CHC, 14 HA, 20 CiOH, 15 OH y 60 CT. IL-12 was found elevated in OH, HA, CHC vs. CT in OH vs. HCc y HGNA (p≤0.05). CXCL-10 was found elevated in CiOH, HA and CHC vs. CT(p≤0.050). Discussion: The IL-12 showed elevated levels in subjects with alcohol consumption and CHC vs. CT that activates other cell types involved in inflammation. CXCL-10 is induced by IFN-γ, was found elevated in CiOH, HA and CHC, exerting their biological effects through CXCR3, including activation of peripheral immune cells and apoptosis. The ratio of IL-12/CXCL-10 in OH increased 4.6 times, ratifying the participation in chronic and continual inflammatory response by alcohol consumption. Conclusions: IL-12 and CXCL-10 have an important role in alcohol-induced liver disease, confirming their contribution to inflammation, being evident CXCL-10 in advanced stages of the disease, by stimulating and favoring the migration of immune cells to the damage sites. Funding: This work was partially financed by CONACyT SALUD-2016-272579 and PAPIIT- UNAM TA200515. Declaration of interest: The authors declare no potential conflicts of interest.
format Article
id eprints-25582
institution UANL
language English
publishDate 2022
publisher Ediciones Medicina y Cultura
record_format eprints
spelling eprints-255822024-03-06T15:25:28Z http://eprints.uanl.mx/25582/ Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption Hernández Santillan, M. Martínez Castillo, M. Medina Avila, Z. Lemus Peña, M Montes de Oca Ángeles, D Hernández Barragán, A. Pérez Hernández, J. L. Higuera de la Tijera, María de Fátima Santana Vargas, D. Cordero Pérez, Paula Muñoz Espinoza, Linda Córdova Gallardo, J. Kershenobich Stalnikowitz, David Gutiérrez Reyes, Gabriela RC Medicina Interna, Psiquiatría, Neurología Introduction and Objectives: To Compare serum levels of IL-12 and CXCL-10 in different etiologies of liver disease. Materials and methods: A cross-sectional and multicenter study was carried out, including subjects with alcoholism according to criteria WHO, without (OH) and with liver injury (cirrhosis, CiOH) and (Alcoholic Hepatitis, HA); non-alcoholic fatty liver (NAFLD) and chronic Hepatitis C (CHC), diagnosed by clinical, biochemical data. They were compared with subjects control (CT). For determination of IL-12 and CXCL-10 with Multiplex®-MERCK©. Statistical analysis by SPSS V.22 using U de Mann Whitney, p<0.05; values expressed as mean ± standard error. Results: Included 20 subjects with NAFLD, 78 CHC, 14 HA, 20 CiOH, 15 OH y 60 CT. IL-12 was found elevated in OH, HA, CHC vs. CT in OH vs. HCc y HGNA (p≤0.05). CXCL-10 was found elevated in CiOH, HA and CHC vs. CT(p≤0.050). Discussion: The IL-12 showed elevated levels in subjects with alcohol consumption and CHC vs. CT that activates other cell types involved in inflammation. CXCL-10 is induced by IFN-γ, was found elevated in CiOH, HA and CHC, exerting their biological effects through CXCR3, including activation of peripheral immune cells and apoptosis. The ratio of IL-12/CXCL-10 in OH increased 4.6 times, ratifying the participation in chronic and continual inflammatory response by alcohol consumption. Conclusions: IL-12 and CXCL-10 have an important role in alcohol-induced liver disease, confirming their contribution to inflammation, being evident CXCL-10 in advanced stages of the disease, by stimulating and favoring the migration of immune cells to the damage sites. Funding: This work was partially financed by CONACyT SALUD-2016-272579 and PAPIIT- UNAM TA200515. Declaration of interest: The authors declare no potential conflicts of interest. Ediciones Medicina y Cultura 2022 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/25582/1/25582.pdf http://eprints.uanl.mx/25582/1.haspreviewThumbnailVersion/25582.pdf Hernández Santillan, M. y Martínez Castillo, M. y Medina Avila, Z. y Lemus Peña, M y Montes de Oca Ángeles, D y Hernández Barragán, A. y Pérez Hernández, J. L. y Higuera de la Tijera, María de Fátima y Santana Vargas, D. y Cordero Pérez, Paula y Muñoz Espinoza, Linda y Córdova Gallardo, J. y Kershenobich Stalnikowitz, David y Gutiérrez Reyes, Gabriela (2022) Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption. Annals of Hepatology, 27. p. 100865. ISSN 16652681 http://doi.org/10.1016/j.aohep.2022.100865 doi:10.1016/j.aohep.2022.100865
spellingShingle RC Medicina Interna, Psiquiatría, Neurología
Hernández Santillan, M.
Martínez Castillo, M.
Medina Avila, Z.
Lemus Peña, M
Montes de Oca Ángeles, D
Hernández Barragán, A.
Pérez Hernández, J. L.
Higuera de la Tijera, María de Fátima
Santana Vargas, D.
Cordero Pérez, Paula
Muñoz Espinoza, Linda
Córdova Gallardo, J.
Kershenobich Stalnikowitz, David
Gutiérrez Reyes, Gabriela
Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
title_full Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
title_fullStr Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
title_full_unstemmed Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
title_short Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
title_sort evaluation of il 12 and cxcl 10 in patients with hepatitis c non alcoholic fatty liver disease and liver damage for alcohol consumption
topic RC Medicina Interna, Psiquiatría, Neurología
url http://eprints.uanl.mx/25582/1/25582.pdf
work_keys_str_mv AT hernandezsantillanm evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT martinezcastillom evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT medinaavilaz evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT lemuspenam evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT montesdeocaangelesd evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT hernandezbarragana evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT perezhernandezjl evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT higueradelatijeramariadefatima evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT santanavargasd evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT corderoperezpaula evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT munozespinozalinda evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT cordovagallardoj evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT kershenobichstalnikowitzdavid evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption
AT gutierrezreyesgabriela evaluationofil12andcxcl10inpatientswithhepatitiscnonalcoholicfattyliverdiseaseandliverdamageforalcoholconsumption